glp1 journey and tirzepatide dosage Switching Between Semaglutide Tirzepatide: Efficacy, Dosing Protocols, and What to Expect Compare GLP-1 Options | Ozempic

Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus in adults (Mounjaro) and chronic weight management (Zepbound) in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity

Retatrutide "mutes" these signals

[PMID: 32767141] PubMed record related to this compound for laboratory literature review

and supporting the gut microbiome

[12] [13] Establishing consistent bowel habits helps train the digestive system

Titrate: 1mg for 4 weeks, increase by 2mg every 4 weeks to maintenance